-
Mashup Score: 3The role of relative advantage for development of sequencing‐based diagnostics for pediatric cancer in low‐ and middle‐income countries - 7 month(s) ago
Efforts to address limitations in cancer diagnostics in low- and middle-income countries should follow an approach that avoids two extremes: unproductive attempts to require implementation of high-in…
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0OnlineFirst - 7 month(s) ago
This site uses cookies. By continuing to use our website, you are agreeing to our privacy
Source: aacrjournals.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Solving a common issue after lymph node removal from cancer - 7 month(s) ago
Surgeons @OSUCCC-James are using advanced microsurgery to solve one of the most common side effects from lymph node removal during cancer surgery: lymphedema.
Source: health.osu.eduCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2YOU can be the difference - 7 month(s) ago
The Leukemia & Lymphoma Society (LLS) is the world’s largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and support services. © 2020 The Leukemia and…
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 6Researcher uses art to share science with a broad audience - 7 month(s) ago
Nick Navin, Ph.D., uses single cell sequencing technologies to better understand breast cancer. But the plotting involved in his work also inspires illustrations influenced by his imagination and aesthetics.
Source: www.mdanderson.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Myelofibrosis alternative treatments - Slides 2023 - 7 month(s) ago
By: John Mascarenhas, MD Date: October 04, 2023 John Mascarenhas, MD, stands as a distinguished authority in the realm of myelofibrosis treatment. Drawing upon his extensive expertise and experience, Dr. Mascarenhas delivered an enlightening presentation in 2023, shedding light on the drugs Pacritinib and Mamelotni…
Source: oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1ColoAlert’s Novel mRNA Biomarkers Demonstrate Sensitivity, Specificity in Detecting CRC, Advanced Adenoma - 7 month(s) ago
The novel mRNA biomarkers in the noninvasive ColoAlert® screening test displayed sensitivity and specificity for detecting colorectal cancer and advanced adenomas that could be precursors to CRC.
Source: www.onclive.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Dr. Barbara Goff, 2023 Dr. Saul E. Rivkin Awardee - 7 month(s) ago
The Rivkin Center honors UW Medicine oncologist and Surgeon-in-Chief, Dr. Barbara Goff, with the second Dr. Saul E. Rivkin award for her tireless work and pa…
Source: www.youtube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3Time to deterioration of patient-reported outcomes as a surrogate of overall survival: a meta-analysis - 7 month(s) ago
AbstractBackground. Overall survival is the optimal marker of treatment efficacy in randomized clinical trials (RCTs) but can take considerable time to mature.
Source: academic.oup.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
The 2024 Multidisciplinary Head and Neck Cancers Symposium will take place February 29-March 2, 2024, in Phoenix, Arizona. This practical and interactive meeting is for the entire head and neck cancer care community.
Source: www.astro.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
New commentary | The role of relative advantage for development of sequencing-based diagnostics for pediatric cancer in low- and middle-income countries 🔗https://t.co/UZUmmNXN4b @oncoalert @UNCDeptMedicine @AbbyRosenbergMD #pedonc https://t.co/hxORQIOzTP